Biotech Stock Report 10.03.09
Tuesday, 10 March, 2009
The pharmaceuticals and biotechnology sector was mostly flat recording a small 0.11% increase for the day.
Market heavyweight CSL (ASX:CSL) was stable, up 28c to $35.44.
Living Cell Technologies (ASX:LCT) recorded spectacular increase of 31%, to close at 10.5c but is still trading near its 52 week low of 8c.
Prana Biotechnology (ASX:PBT) and IDT Australia (ASX:IDT) were among the day's weaker performers in the pharmaceuticals and biotechnology sector, down 8% and 6% respectively with Bionomics Limited (ASX:BNO) not far behind, 5% down to 20c.
Chemgenex Pharmaceuticals (ASX:CXS) recorded a solid 6% rise to 34c, but is still well down on its 52 week high of $1.25. Novogen and Progen also moved up over 3%.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
